The Role of Noncoding RNA Antisense Transcript of the B-Cell Translocation Gene 3 Regulation of BTG3 in Pancreatic Ductal Adenocarcinoma Tumor Progression.

Antisense transcript of the B-cell translocation gene 3 (ASBEL) is a highly conserved antisense non-coding RNA (ncRNA) and participates in a variety of biological processes. However, the ASBEL expression status in pancreatic ductal adenocarcinoma (PDAC) and its correlation with BTG3 expression and t...

Descripción completa

Detalles Bibliográficos
Publicado en:Current Therapeutic Research Vol. 98
Autores principales: Chen, Jing, Zhu, Ming-Yuan, Huang, Yan-Hua, Ling, Yi-Ting, Gu, Tian-Yuan, Zhou, Quan, Fei, Ming-Jian, Zhou, Zhong-Cheng
Formato: research Journal Article
Publicado: Elsevier B.V. 2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=164402091&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 164402091
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0011393X
        KIH
      jtl: Current Therapeutic Research
      issn: 0011393X
      maglogo: N
    pubinfo:
      dt: 2023
      vid: 98
      pid: 467
      pub: Elsevier B.V.
      place: New York, New York
    artinfo:
      ui:
        164402091
        164402091
        164402091
        10.1016/j.curtheres.2023.100700
        164402091
      ppct: 1
      formats:
      tig:
        atl: The Role of Noncoding RNA Antisense Transcript of the B-Cell Translocation Gene 3 Regulation of BTG3 in Pancreatic Ductal Adenocarcinoma Tumor Progression.
      aug:
        au:
          Chen, Jing
          Zhu, Ming-Yuan
          Huang, Yan-Hua
          Ling, Yi-Ting
          Gu, Tian-Yuan
          Zhou, Quan
          Fei, Ming-Jian
          Zhou, Zhong-Cheng
        affil: Department of General Surgery, The Second Affiliated Hospital of Jiaxing University, Zhejiang Province, China
      sug:
        subj:
          Pancreatic Neoplasms Familial and Genetic
          Carcinoma, Ductal Familial and Genetic
          Pancreatic Neoplasms Physiopathology
          Carcinoma, Ductal Physiopathology
          Disease Progression Physiopathology
          RNA Physiology
          B Lymphocytes
          Gene Expression Profiling
          Human
          Animal Studies
          In Vitro Studies
          In Vivo Studies
          Blotting, Western
          Polymerase Chain Reaction
          Cell Count
          Flow Cytometry
          Cell Proliferation
          Apoptosis
          Neoplasm Invasiveness
          Cell Movement
          Xenografts
          Mice
          Models, Biological
          Tumor Markers, Biological
      ab: Antisense transcript of the B-cell translocation gene 3 (ASBEL) is a highly conserved antisense non-coding RNA (ncRNA) and participates in a variety of biological processes. However, the ASBEL expression status in pancreatic ductal adenocarcinoma (PDAC) and its correlation with BTG3 expression and tumor cell progression were not completely clear. We conducted cell experiments and animal experiments to confirm that ASBEL plays a crucial role in the tumorigenesis of PDAC by targeting BTG3. ASBEL regulation in PDAC tumorigenesis was evaluated using Western blotting, quantitative polymerase chain reaction, Cell Counting Kit-8 assay, flow cytometry, and cell transfection. We also evaluated the expression of ASBEL and BTG3 in tumor tissues and cells using Western blotting and quantitative real-time polymerase chain reaction. Finally, we explored the role of ASBEL in tumor development by silencing or overexpressing ASBEL gene in AsPC-1 or CFPAC-1 cells, respectively, and evaluated the antitumor activity in vivo using an ASBEL antagonist. Our study revealed the expression of ASBEL in all pancreatic cell lines. The expression level of ASBEL in tumor tissues was found to be higher than that of paracarcinomatous tissues. ASBEL suppresses expression of BTG3 , enhances proliferation and suppresses apoptosis, and promotes migration and invasion in pancreatic cancer cell. Antagonist regulates the expression of ASBEL in AsPC-1, and suppresses tumor growth in xenograft mouse model. Our results indicate that ASBEL may play a tumor-promoting factor in PDAC by targeting BTG3 and could be as an important biomarker for PDAC treatment. (Curr Ther Res Clin Exp. 2023; 84:XXX–XXX).
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N